QA: Catalent Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001596783_2022_Catalent_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 2.528811086797958, 'aggregate_val': 4838000000, 'exp_sum': 1371000000, 'exp_to_value': {'LiabilitiesCurrent': 1196000000, 'LiabilitiesNoncurrent': 175000000, 'remainder_Liabilities': 0}}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 3.5427892234548337, 'aggregate_val': 5733000000, 'exp_sum': 1262000000, 'exp_to_value': {'LiabilitiesCurrent': 1098000000, 'LiabilitiesNoncurrent': 164000000, 'remainder_Liabilities': 0}}

Graph

Absolute values for 0001596783, Catalent Inc

  xvar xval
0 AssetsCurrent 2,918,000,000
1 IntangibleAssetsNetIncludingGoodwill 3,336,000,000
2 PropertyPlantAndEquipmentNet 2,524,000,000
3 remainder_Assets 334,000,000
4 LiabilitiesCurrent 1,196,000,000
5 LiabilitiesNoncurrent 175,000,000
6 remainder_Liabilities 3,467,000,000
7 CostOfGoodsAndServicesSold 2,863,414,271
8 SellingGeneralAndAdministrativeExpense 701,402,575
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 143,192,429
11 remainder_Revenues 4,208,869,779
12 remainder_NetIncome 31,585,490
13 remainder_ComprehensiveNetIncome 41,069,820
  yvar yval
0 Assets 9,112,000,000
1 Liabilities 4,838,000,000
2 Expenses 3,708,009,275
3 Revenues 4,208,869,779
4 StockholdersEquity 4,274,000,000
5 NetIncome 532,445,994
6 ComprehensiveNetIncome 552,980,904
7 BaseVar 10,969,767,182
8 EconomicCapitalRatiobeforeLimitedLiability 1.42
9 EconomicCapitalRatio 2.62

Edgar->Model Mapping

Feature Distribution

Change over Time